CVE:MDX - MedX Health Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.12
▲ +0.005 (4.55%)

This chart shows the closing price for MDX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MedX Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDX

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for MedX Health in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$0.12.

This chart shows the closing price for MDX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in MedX Health. This rating has held steady since February 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/25/2020Beacon SecuritiesReiterated RatingBuy
(Data available from 10/23/2016 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/25/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/23/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/23/2021

Current Sentiment

  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

MedX Health

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: C$0.12
Low: C$0.11
High: C$0.12

50 Day Range

MA: C$0.12
Low: C$0.12
High: C$0.13

52 Week Range

Now: C$0.12
Low: C$0.10
High: C$0.26

Volume

39,500 shs

Average Volume

237,023 shs

Market Capitalization

C$20.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MedX Health?

The following Wall Street research analysts have issued reports on MedX Health in the last year:
View the latest analyst ratings for MDX.

What is the current price target for MedX Health?

0 Wall Street analysts have set twelve-month price targets for MedX Health in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for MedX Health in the next year.
View the latest price targets for MDX.

What is the current consensus analyst rating for MedX Health?

MedX Health currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MDX.

How do I contact MedX Health's investor relations team?

MedX Health's physical mailing address is 1495 Bonhill Rd Unit 1, MISSISSAUGA, ON L5T 1M2, Canada. The company's listed phone number is +1-905-6704428. The official website for MedX Health is www.medxhealth.com.